Quiz: Reviewing Allergy and Asthma Triggers

Quiz
Article
Disease Awareness |Allergy and Asthma Awareness Month

Test your knowledge of asthma and allergy triggers.

May is Asthma and Allergy Awareness Month. Each week, Drug Topics will be publishing a themed quiz to help readers test their knowledge in a specific area of asthma and allergy management.

How much do you know about asthma and allergy triggers? Take the quiz below, and check back tomorrow for our breakdown of the answers.

Question 1

Which of the following is not a common indoor allergen trigger for asthma and allergies?


Related Content
Black, Hispanic Patients Underrepresented in Food Allergy Immunotherapy Trials

Black, Hispanic Patients Underrepresented in Food Allergy Immunotherapy Trials

Brian Nowosielski
November 13th 2024
Article

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.

Why Vaccination Uptake is Crucial During the Winter Season

Why Vaccination Uptake is Crucial During the Winter Season

Brian Nowosielski
November 6th 2024
Article

Ruth Carrico, PhD, DNP, APRN, sat down with Drug Topics to discuss the importance of COVID-19 and influenza vaccination.

Women with Delayed Menopause May Face Increased Risk of Asthma

Women with Delayed Menopause May Face Increased Risk of Asthma

Lauren Massaro
October 30th 2024
Article

Women experiencing later menopause may face a heightened risk of asthma, underscoring the possible role of estrogen in the development of the condition.

Education Resources Affect Pharmacy Pneumococcal Vaccination Conversations

Education Resources Affect Pharmacy Pneumococcal Vaccination Conversations

Hannah Dellabella
October 21st 2024
Article

Pharmacist education can positively impact patient counseling around vaccinations in older adults.

Pharmacists as Key Players in Managing Chronic Conditions | ACCP 2024

Pharmacists as Key Players in Managing Chronic Conditions | ACCP 2024

Lauren Massaro
October 18th 2024
Article

Pharmacist management of chronic conditions can lead to improved patient outcomes.

FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary Disease

FDA Approves Ensifentrine, Novel Treatment for Chronic Obstructive Pulmonary Disease

Kevin W. Chamberlin, PharmD, FASCP;Molly Csere, PharmD
October 15th 2024
Article

On June 26, 2024, the FDA approved ensifentrine (Ohtuvayre) for the treatment of COPD.

© 2024 MJH Life Sciences

All rights reserved.